# Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa

> **NCT01754129** · — · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 148 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01754129
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2018-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01754129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01754129, "Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01754129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*